Youngevity International (YGYI) Stock Price, News & Analysis

Company Overview

Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers cannabidiol oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network. Youngevity International, Inc. also markets its products through a range of consumer Websites, such as youngevity.com; ygyi.com; heritagemakers.com; hempfx.com; clrroasters.com; cafelarica.com; javalution.com. The company was formerly known as AL International, Inc. and changed its name to Youngevity International, Inc. in July 2013. Youngevity International, Inc. was founded in 1996 and is headquartered in Chula Vista, California.

Key Stats

• Today's Range: $0.0111 to $0.0111
• 50-Day Range: $0.29 to $0.39
• 52-Week Range: $0.24 to $2.74
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $450,660.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YGYI Stock Analysis - Frequently Asked Questions

How were Youngevity International's earnings last quarter?

Youngevity International, Inc. (NASDAQ:YGYI) issued its quarterly earnings results on Tuesday, April, 16th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.06) by $0.40. The firm had revenue of $36.11 million for the quarter.

What other stocks do shareholders of Youngevity International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Youngevity International investors own include NewAge (NBEV), Allena Pharmaceuticals (ALNA), Neptune Wellness Solutions (NEPT), TherapeuticsMD (TXMD), Zynerba Pharmaceuticals (ZYNE), Amyris (AMRS) and Canopy Growth (CGC).

Company Calendar

• Last Earnings: 4/16/2019
• Today: 4/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Catalog & mail - order houses
• Sub-Industry: N/A
• Current Symbol: NASDAQ:YGYI
• CIK: 1569329
• Web: www.ygyi.com
• Phone: 619-934-3980
• Fax: 619-934-3205
• Employees: 469
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 40,600,000
• Free Float: 18,028,000
• Market Cap: $450,660.00
• Optionable: Not Optionable
• Beta: N/A